ISMRM/SMRT Joint Forum
Nephrogenic Systemic Fibrosis - A Multidisciplinary and Global Issue
Organizer: David W. Stanley, B.S., R.T.(R)(MR)
Skill Level: Intermediate
Monday 5 May 2008
Described in 2000, nephrogenic systemic fibrosis (NSF) is an emerging systemic disorder characterized by widespread tissue fibrosis. This two-hour forum will provide participants with the most current information concerning the onset of NSF after the administration of intravenous contrast material for MR imaging (i.e., gadolinium chelates). Understanding the issue of NSF and careful patient management prior to the administration of gadolinium contrast agents is now a requirement of consideration for all clinicians and technologists globally.
Upon completion of this course, participants should be able to:
This course is designed for radiological technologists, radiographers, radiologists, physicists, scientists, MR trainees, and all working with MR.
|14:00||NSF: Where have we been, where are we going||Emanuel Kanal, M.D., F.A.C.R.|
|14:25||NSF: Challenges of Gadolinium and NSF outside of North America||Tim Leiner, Ph.D.|
|14:45||Gadolinium and NSF: Risk factor screening and contrast administration||Eric E. Williamson, M.D.|
|15:05||NSF Management: A Technologist Perspective||Cindy R. Comeau, B.S., R.T. (N)(MR)|